Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
A/B Sciex AB
AB
Active
Org 5567900922
Östermalmstorg 1, 114 42
Stockholm
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2009 · 16 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
A/B Sciex AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
32M
24M
16M
8M
0M
2020: 17M
17M
2020
2021: 20M (+18% vs 2020)
20M
+18%
2021
2022: 19M (-5% vs 2021)
19M
-5%
2022
2023: 25M (+32% vs 2022)
25M
+32%
2023
2024: 26M (+4% vs 2023)
26M
+4%
2024
EBITDA
SEK millions
2M
2M
1M
1M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 2M (+100% vs 2022)
2M
+100%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
26 285
24 835
18 826
19 971
16 776
Staff expenses
—
—
—
—
—
EBITDA
1 667
1 679
1 104
871
681
Depreciation & amort.
−524
−254
−0
−0
−40
EBIT
1 143
1 425
1 104
871
641
Net financials
226
26
18
−1
−1
Profit before tax
1 368
1 451
1 122
870
640
Tax
−283
−300
−232
−237
−97
Net profit
1 085
1 151
890
633
543
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
13 165
12 398
10 201
9 605
8 662
Equity
7 224
6 139
4 988
4 098
3 465
Long-term debt
0
0
0
0
0
Short-term debt
5 941
6 259
5 212
5 507
5 197
Total debt
5 941
6 259
5 212
5 507
5 197
Financial ratios
5-year trend
EBITDA margin
6,3 %
This company
15,8 %
Market median
This company
Market median
60% below market
2020
2024
Equity ratio
54,9 %
This company
38,2 %
Market median
This company
Market median
44% above market
2020
2024
Return on equity
15,0 %
This company
18,4 %
Market median
This company
Market median
18% below market
2020
2024
Net profit margin
4,1 %
This company
8,1 %
Market median
This company
Market median
49% below market
2020
2024
Asset turnover
2,00×
This company
1,12×
Market median
This company
Market median
79% above market
2020
2024
Debt / equity
0,82×
This company
0,62×
Market median
This company
Market median
32% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on A/B Sciex AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network